RxDoctor Payments Data

Jeannine Smith

Physician Assistant · Mineola, NYNPI 1396065025

Payments from drug & device makers

$2,396in general payments, 2019–2025

Across 119 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$429
  • Boston Scientific$296
  • Scilex Pharmaceuticals Inc.$242
  • Forte Bio-pharma LLC$203
  • Tersera Therapeutics LLC$178
  • MML US, Inc.$165
  • plus $883 from 16 others

What the payments were for

  • Food & beverage$2,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,396 in reported general payments places this provider in the 85th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl32$32,857
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen212$7,245
Diclofenac Sodium19$5,412
Buprenorphine26$5,326
Oxycodone Hcl220$5,213
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$3,560
Pregabalin94$3,504
Lidocaine22$2,351
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen108$2,314
Gabapentin185$1,890
Tizanidine Hcl68$1,291
Morphine Sulfate ErMorphine Sulfate40$1,158
Methadone Hcl41$946
Methocarbamol45$564
Duloxetine Hcl39$521

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone$92$8,88644 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Mineola

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →